| adrenaline | <hormone> A hormone produced by the adrenal medulla in mammals. It can be produced synthetically for medical purposes. It is secreted by the adrenal medulla in response to low blood glucose, exercise and stress and causes a breakdown of glycogen to glucose in the liver, encourages the release of fatty acids from adipose tissue, causes vasodilation of the small arteries within muscle and increases cardiac output. (27 Sep 1997) |
|---|---|
| adrenaline oxidase | amine oxidase (flavin-containing) |
| adrenaline reversal | The fall in blood pressure produced by epinephrine when given following blockage of alpha-adrenergic receptors by an appropriate drug such as phenoxybenzamine; the vasodilation reflects the ability of epinephrine to activate beta-adrenergic receptors which, in vascular smooth muscle, are inhibitory; in the absence of alpha-receptor blockade, the beta-receptor activation by epinephrine is masked by its predominant action on vascular alpha-receptors, which causes vasoconstriction. Synonym: adrenaline reversal. (05 Mar 2000) |
| NAD(P)H-adrenaline oxidase | <enzyme> Forms adrenochrome Registry number: EC 1.6.- (26 Jun 1999) |
| acid tartrate | A salt of tartaric acid which contains an acid group still capable of combining with a base; e.g., bitartrate. (05 Mar 2000) |
| potassium acid tartrate | KHC4H4O6;a diuretic and laxative. Synonym: cream of tartar, potassium acid tartrate. (05 Mar 2000) |
| noradrenaline acid tartrate | norepinephrine bitartrate |
| tartrate-resistant acid phosphatase | <biochemistry, enzyme> Acid phosphatase is present in bone, prostate, platelets, erythrocytes and spleen. Osteoclasts contain an isoenzyme that is resistant to tartrate, whereas, the isoenzyme in the prostate is sensitive. Tartrate-resistant acid phosphatase is elevated in the serum of patients with primary hypoparathyroidism, Paget disease, vertebral osteoporosis, T-cell lymphoma and in women after oophorectomy. Oestrogen replacement in osteoporotic postmenopausal women is associated with a decrease in tartrate-resistant acid phosphatase of 70% over 3 to 6 months. Acronym: TRAP (16 Dec 1997) |
| antimony potassium tartrate | <chemical> Bis(mu-(2,3-dihydroxybutanedioato(4-)-o(1),o(2):o(3),o(4)))diantimonate(2-) dipotassium trihydrate, stereoisomer. A schistosomicide possibly useful against other parasites. It has irritant emetic properties and may cause lethal cardiac toxicity among other adverse effects. Pharmacological action: schistosomicides. Chemical name: Antimonate(2-), bis(mu-(2,3-dihydroxybutanedioato(4-)-O1,O2:O3,O4))di-, dipotassium, trihydrate, stereoisomer (12 Dec 1998) |
| antimony sodium tartrate | Na(SbO)C4H4O6;used in the treatment of schistosomiasis, and as an emetic. Synonym: sodium antimonyl tartrate. (05 Mar 2000) |
| bismuth sodium tartrate | A basic sodium bismuth tartrate; an antisyphilitic agent. (05 Mar 2000) |
| butorphanol tartrate | (-)-17-(Cyclobutylmethyl)morphinan-3,14-diol tartrate;a potent mixed agonist/antagonist narcotic analgesic agent. (05 Mar 2000) |
| pentolinium tartrate | <chemical> A nicotinic antagonist that has been used as a ganglionic blocking agent in hypertension. Pharmacological action: antihypertensive agents, ganglionic blockers, nicotinic antagonists. Chemical name: Pyrrolidinium, 1,1'-(1,5-pentanediyl)bis(1-methyl-, salt with (R-(R*,R*))-2,3-dihydroxybutanedioic acid (1:2) (12 Dec 1998) |
| meso-tartrate dehydrogenase | <enzyme> Forms dihydroxyfumarate; distinguished from EC 1.1.1.93 which forms oxaloglycollate Registry number: EC 1.3.1.7 (26 Jun 1999) |
| metoprolol tartrate | 1-Isopropylamino-3-[p-(2-methoxyethyl)phenoxy]-2-propanol (2:1) dextrotartrate salt;a beta-adrenergic blocking agent used in the treatment of hypertension; exhibits some cardioselectivity. (05 Mar 2000) |